Theravance Biopharma Inc (NASDAQ: TBPH), a Cayman Islands-based biopharmaceutical company, has named Deepika R Pakianathan, PhD as its new director, it was reported on Thursday.
Dr Pakianathan has served as a vice president at JP Morgan, biotechnology research analyst at Genesis Merchant Group, postdoctoral scientist in the Immunology Department at Genentech Corporation and a managing member at Delphi Ventures. Presently, she serves on the boards of Calithera Biosciences Inc, Karyopharm Therapeutics Inc, and Mereo BioPharma Group PLC.
Dr Pakianathan holds a PhD and MS from Wake Forest University and an MSc and BSc from the University of Bombay.
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management